featured
Effectiveness of Cladribine Tablets vs Other Oral Disease-Modifying Treatments for MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Mult. Scler. 2022 Nov 26;[EPub Ahead of Print], T Spelman, S Ozakbas, R Alroughani, M Terzi, S Hodgkinson, G Laureys, T Kalincik, A Van Der Walt, B Yamout, J Lechner-Scott, A Soysal, J Kuhle, JL Sanchez-Menoyo, Y Blanco Morgado, D Spitaleri, V van Pesch, D Horakova, R Ampapa, F Patti, R Macdonell, A Al-Asmi, O Gerlach, J Oh, A Altintas, N Tundia, SL Wong, H ButzkuevenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.